These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1593027)

  • 1. Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with attention-deficit hyperactivity disorder.
    Carlson CL; Pelham WE; Milich R; Dixon J
    J Abnorm Child Psychol; 1992 Apr; 20(2):213-32. PubMed ID: 1593027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.
    Pelham WE; Gnagy EM; Burrows-Maclean L; Williams A; Fabiano GA; Morrisey SM; Chronis AM; Forehand GL; Nguyen CA; Hoffman MT; Lock TM; Fielbelkorn K; Coles EK; Panahon CJ; Steiner RL; Meichenbaum DL; Onyango AN; Morse GD
    Pediatrics; 2001 Jun; 107(6):E105. PubMed ID: 11389303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separate and combined effects of methylphenidate and behavior modification on boys with attention deficit-hyperactivity disorder in the classroom.
    Pelham WE; Carlson C; Sams SE; Vallano G; Dixon MJ; Hoza B
    J Consult Clin Psychol; 1993 Jun; 61(3):506-515. PubMed ID: 8326053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG; Kolko DJ
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Gnagy EM; Chronis AM; Burrows-MacLean L; Fabiano GA; Onyango AN; Meichenbaum DL; Williams A; Aronoff HR; Steiner RL
    Pediatrics; 1999 Dec; 104(6):1300-11. PubMed ID: 10585981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies.
    Northup J; Fusilier I; Swanson V; Huete J; Bruce T; Freeland J; Gulley V; Edwards S
    J Appl Behav Anal; 1999; 32(1):35-50. PubMed ID: 10201102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does methylphenidate normalize the classroom performance of children with attention deficit disorder?
    DuPaul GJ; Rapport MD
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):190-8. PubMed ID: 8428871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of evaluating methylphenidate in children with attention deficit hyperactivity disorder: acceptability, satisfaction, and compliance.
    Johnston C; Fine S
    J Pediatr Psychol; 1993 Dec; 18(6):717-30. PubMed ID: 8138866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of methylphenidate and behavioral intervention on classroom behavior in children with ADHD and mental retardation.
    Johnson CR; Handen BL; Lubetsky MJ; Sacco KA
    Behav Modif; 1994 Oct; 18(4):470-87. PubMed ID: 7980374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.
    Rapport MD; Denney C; DuPaul GJ; Gardner MJ
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):882-93. PubMed ID: 8083146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior.
    Pelham WE; Bender ME; Caddell J; Booth S; Moorer SH
    Arch Gen Psychiatry; 1985 Oct; 42(10):948-52. PubMed ID: 3899046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of methylphenidate and expectancy on children with ADHD: behavior, academic performance, and attributions in a summer treatment program and regular classroom settings.
    Pelham WE; Hoza B; Pillow DR; Gnagy EM; Kipp HL; Greiner AR; Waschbusch DA; Trane ST; Greenhouse J; Wolfson L; Fitzpatrick E
    J Consult Clin Psychol; 2002 Apr; 70(2):320-35. PubMed ID: 11952190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.
    Kolko DJ; Bukstein OG; Barron J
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
    Childress AC; Kollins SH; Cutler AJ; Marraffino A; Sikes CR
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):66-74. PubMed ID: 27183299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.